Form 4: Zeo ScientifiX Interim CEO & CFO, Ian T. Bothwell, Granted Stock Options
SEC Form 4 Filing
Ian T. Bothwell, Interim CEO & CFO of Zeo ScientifiX, Inc., reports the acquisition of 55,000 stock options under the company's 2021 Equity Incentive Plan.
Summary
- On May 8, 2025, Ian T. Bothwell, the Interim CEO & CFO of Zeo ScientifiX, Inc., was granted 55,000 stock options.
- These options are exercisable for common stock of the company.
- The exercise price of the options is $2.86.
- The options vested fully on the grant date, May 8, 2025, and expire on May 8, 2030.
- The grant was made under the company's 2021 Equity Incentive Plan.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard executive compensation practice. The immediate vesting could be seen as slightly positive, but overall, it's an expected event.
Positives
- The grant of stock options to the Interim CEO & CFO aligns his interests with those of the shareholders.
- The immediate vesting of the options may incentivize him to drive short-term performance.
Industry Context
Stock option grants are a common form of executive compensation in the technology and science industries, aligning management's interests with shareholder value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages, particularly in growth-oriented companies like Zeo ScientifiX.
- The size of the grant (55,000 options) would need to be compared to grants at peer companies of similar size and stage to determine if it is within industry norms.
- Companies like Amgen, Biogen, and Gilead Sciences also use stock options as part of their compensation packages.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- It incentivizes the Interim CEO & CFO, potentially benefiting shareholders through improved company performance.
Key Dates
| Date | Description |
|---|---|
| 05/08/2025 | Date of stock option grant and vesting. |
| 05/08/2030 | Expiration date of the stock options. |
Keywords
Stock Options, Equity Incentive Plan, Form 4, Beneficial Ownership, Zeo ScientifiX, Bothwell, CEO, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.